Showing results (191-200 of 264) with videos related to
Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximabJaveed Iqbal, Paul N Meyer, Lynette M Smith, et al.Cancer Research|March 15, 2024
NCI Cancer Research Data Commons: Resources to Share Key Cancer DataZhining Wang, Tanja M Davidsen, Gina R Kuffel, et al.Blood|November 24, 2021
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphomaTakashi Ishio, Sarvesh Kumar, Joji Shimono, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.The Journal of Clinical Investigation|October 8, 2009
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted modelsJames G Taylor, Adam T Cheuk, Patricia S Tsang, et al.Nature|October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphomaJagan R Muppidi, Roland Schmitz, Jesse A Green, et al.Blood|March 1, 2012
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingKaren E Deffenbacher, Javeed Iqbal, Warren Sanger, et al.Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.Pageof 27